Cargando…

Corrigendum: Anakinra Therapy for Non-cancer Inflammatory Diseases

Detalles Bibliográficos
Autores principales:	Cavalli, Giulio, Dinarello, Charles A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418949/ https://www.ncbi.nlm.nih.gov/pubmed/30906259 http://dx.doi.org/10.3389/fphar.2019.00148

Ejemplares similares

Anakinra Therapy for Non-cancer Inflammatory Diseases
por: Cavalli, Giulio, et al.
Publicado: (2018)

Continuous IV infusion of anakinra
por: Saunders, Brittney N., et al.
Publicado: (2023)

Long-Term Retention Rate of Anakinra in Adult Onset Still’s Disease and Predictive Factors for Treatment Response
por: Vitale, Antonio, et al.
Publicado: (2019)

Effect of anakinra in COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

Anakinra for patients with COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

Comparison of the effects of erythropoietin and anakinra on functional recovery and gene expression in a traumatic brain injury model
por: Anderson, Gail D., et al.
Publicado: (2013)

Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease
por: Sota, Jurgen, et al.
Publicado: (2019)

Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies.
por: Pasin, Laura, et al.
Publicado: (2021)

Corrigendum: Targeted therapy in cardiovascular disease: A precision therapy era
por: Xu, Mengda, et al.
Publicado: (2023)

Corrigendum: Docetaxel-loaded novel nano-platform for synergistic therapy of non-small cell lung cancer
por: Feng, Xing, et al.
Publicado: (2022)

Efficacy of anakinra on rebound of multisystem inflammatory syndrome
por: Brisca, Giacomo, et al.
Publicado: (2022)

Corrigendum: Advances in non-dopaminergic pharmacological treatments of Parkinson's disease
por: Stayte, Sandy, et al.
Publicado: (2014)

Peri- and Postoperative Treatment with the Interleukin-1 Receptor Antagonist Anakinra Is Safe in Patients Undergoing Renal Transplantation: Case Series and Review of the Literature
por: Mulders-Manders, Catharina M., et al.
Publicado: (2017)

Corrigendum: R-carvedilol, a potential new therapy for Alzheimer’s disease
por: Yao, Jinjing, et al.
Publicado: (2023)

Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy
por: Bhagwat, Geeta S., et al.
Publicado: (2023)

Corrigendum: Inflammatory Stress Potentiates Emodin-Induced Liver Injury in Rats
por: Tu, Can, et al.
Publicado: (2021)

Corrigendum: Targeting Myc Interacting Proteins as a Winding Path in Cancer Therapy
por: Zhou, Yihui, et al.
Publicado: (2021)

Corrigendum: Prostaglandin reductase 1 as a potential therapeutic target for cancer therapy
por: Wang, Xing, et al.
Publicado: (2023)

Editorial: Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
por: Ribeiro, Carla Maria Pedrosa, et al.
Publicado: (2021)

Corrigendum: Research advances in drug therapy of endometriosis
por: Shi, Jianyou, et al.
Publicado: (2023)

Corrigendum: Research advances in drug therapy of endometriosis
por: Shi, Jianyou, et al.
Publicado: (2023)

Corrigendum: Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor
por: Grohs, Laura, et al.
Publicado: (2023)

Anakinra in children and adults with Still’s disease
por: Vastert, Sebastiaan J, et al.
Publicado: (2019)

Cerebral autoinflammatory disease treated with anakinra
por: Jang, Yoonhyuk, et al.
Publicado: (2018)

Novel and Emerging Therapies for Inflammatory Bowel Disease
por: Al-Bawardy, Badr, et al.
Publicado: (2021)

Corrigendum: Improving therapy of pharmacoresistant epilepsies: The role of fenfluramine
por: Dini, Gianluca, et al.
Publicado: (2023)

Corrigendum: Nanostructured lipid carrier–mediated transdermal delivery of aceclofenac hydrogel present an effective therapeutic approach for inflammatory diseases
por: Garg, Neeraj K., et al.
Publicado: (2022)

Anakinra in Refractory Multisystem Inflammatory Syndrome in Children (MIS-C)
por: Bhat, Chandrika S., et al.
Publicado: (2021)

Corrigendum: Discoidin Domain Receptors: Potential Actors and Targets in Cancer
por: Rammal, Hassan, et al.
Publicado: (2016)

Corrigendum: Adenosine kinase on deoxyribonucleic acid methylation: Adenosine receptor-independent pathway in cancer therapy
por: Luo, Hao-Yun, et al.
Publicado: (2023)

Comparison of Anakinra and Tocilizumab in Anticytokine Therapy in the Treatment of Coronavirus Disease-2019
por: Ozkan, Feyza, et al.
Publicado: (2022)

Corrigendum: The Mechanism of Aureusidin in Suppressing Inflammatory Response in Acute Liver Injury by Regulating MD2
por: Yang, Yi, et al.
Publicado: (2021)

Corrigendum: Effect of Acetaminophen Ingestion on Thermoregulation of Normothermic, Non-febrile Humans
por: Foster, Josh, et al.
Publicado: (2016)

Corrigendum: A Prognostic Model Based on Immune-Related Long Non-Coding RNAs for Patients With Cervical Cancer
por: Chen, Peijie, et al.
Publicado: (2021)

Systemic inflammatory markers and EEG features of children with FIRES receiving anakinra
por: Lai, Yi‐Chen, et al.
Publicado: (2023)

Use of Continuous Intravenous Anakinra Infusion in Multisystem Inflammatory Syndrome in Children
por: Alolayan, Abdulaziz, et al.
Publicado: (2023)

Anakinra restores cellular proteostasis by coupling mitochondrial redox balance to autophagy
por: van de Veerdonk, Frank L., et al.
Publicado: (2022)

Corrigendum: In utero therapy for congenital disorders using amniotic fluid stem cells
por: Ramachandra, Durrgah L., et al.
Publicado: (2015)

Corrigendum: Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States
por: Iglesias-Lopez, Carolina, et al.
Publicado: (2020)

Corrigendum: Improved diagnosis of inflammatory bowel disease and prediction and monitoring of response to anti-TNF alpha treatment based on measurement of signal transduction pathway activity
por: Bouwman, Wilbert, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3rgolgdpdmu4d56giv2du6qhje